Stocks · Health care · Pharmaceutical Preparations

Veraxa Biotech AG - Post de-SPAC

VRXA
Switzerland Fiscal year ends December CIK 0002079109
$1.26 +15.60% Close, 9 Oct 2026
Price $1.26 −49.19% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Jun 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Financial statements

Nothing filed here yet

No statements have been read for VRXA. They arrive with the nightly refresh; a company joins the screen the first time one is.